Max Robotics — Global Service Robot Directory + US Certification

About

Weiwei Zhao is an emerging clinical researcher specializing in stroke rehabilitation and robotic-assisted therapy, with a particular focus on improving motor recovery and functional outcomes in post-stroke patients. Zhao's work centers on the application of exoskeleton rehabilitation robots as innovative tools for restoring balance and lower limb function in individuals recovering from stroke. Zhao's most notable contribution is a 2024 pilot randomized controlled trial investigating the REX exoskeleton rehabilitation robot in sub-acute stroke patients, which has already garnered an impressive 49 citations — a remarkable achievement for such a recent publication, signaling strong interest from the rehabilitation medicine community. This study provided early evidence supporting the integration of robotic exoskeletons into conventional stroke recovery protocols. A complementary 2024 randomized controlled trial further examined the efficacy and safety of unilateral lower limb exoskeletons combined with traditional treatment approaches in post-stroke hemiplegia, contributing additional clinical validation to the field. Zhao's research addresses a critical gap in rehabilitation science by rigorously evaluating emerging technologies that could transform patient care for the millions affected by stroke-related disability each year. For students and clinicians interested in neurorehabilitation and robotic medicine, Zhao's rapidly cited work represents an important and timely contribution to evidence-based practice.